Greenwood Group, NCL & Associates announce strategic alliance
BUFFALO, N.Y. Greenwood Group and NCL & Associates on Tuesday announced a strategic alliance designed to offer a wide variety of services to companies that are at various stages of their development and to provide a platform for success.
Effective Sept. 1, NCL will focus its consulting work in four core areas — diabetes products, services and information; pre-market and pre-commercialization of healthcare products and related services; private equity/venture capital assistance and research; and consulting for retailers, wholesalers and other trade channels.
“NCL & Associates has consulted in these areas prior to me taking full-time positions with Bayer HealthCare as director of trade sales and marketing for [its] diabetes care division and then at Greenwood as VP strategy and consulting,” stated Neil Luckianow, head of NCL. “Re-opening NCL & Associates provides a venue to utilize my strength and supply clients with a focus on outcomes-based research with an emphasis for getting the businesses ready for their next phase and execution. NCL will furnish an integral precommercialization consulting role and deliver a variety of skills and experience to each project.”
“[Luckianow] has been a tremendous resource for us for the past 15 months” commented Patrick O’Leary, Greenwood Group president. “The greatest strength of this partnership is that we will continue everything we began just over a year ago. With NCL, we’ll both get a more independent view of the business environment, which we feel will help our constituents. Both of our companies, as a result, will perform even better and in the end net the kind of outcome that keeps us on our main task — building businesses.”
“From early-stage research and strategic planning through execution of plans and programs, this alliance will give us the opportunity to custom fit a number of services to each client’s business needs,” Luckianow added.
Consumers more loyal to Tylenol brand
PHILADELPHIA According to a study released by the Relational Capital Group, despite product recalls and a plant closure, consumer purchase intent and brand loyalty for Tylenol still currently exceeds that of Advil.
According to the study, conducted by Princeton University professors Susan Fiske and Nicolas Kervyn, 76% of consumers reported positive purchase intent and 67% reported positive brand loyalty for Tylenol, compared with 75% and 65% for Advil, respectively. In addition, Tylenol matched or surpassed Advil on most warmth and competence dimensions, including “acts with your best interests in mind.” Warmth and competence dimensions are both indicators of brand loyalty.
“This suggests that despite how painful the product recalls and plant closure have been for [McNeil Consumer], it appears their efforts thus far have been effective in retaining consumer trust and brand loyalty,” stated Chris Malone, chief advisory officer of The Relational Capital Group.
Conducted July 1 to 7, this study measured the warmth and competence perceptions and priorities of a demographically balanced sample of 1,042 U.S. adult consumers for eight national brands, as well as their purchase intent and brand loyalty toward each. The brands examined included McDonalds, Burger King, BP, Shell, Tropicana, Minute Maid, Tylenol and Advil.
TransMedia Group to promote IntelliGender’s Gender Prediction Test
BOCA RATON, Fla. TransMedia Group on Monday reported it has been retained by IntelliGender to promote that company’s Gender Prediction Test, a simple-to-use urine test that provides immediate gender results.
“Our publicity will focus on promoting IntelliGender as a fun pre-birth experience for expectant mothers who just can’t wait to know,” stated Allison McCormick, public relations manager at TransMedia. “Their unique product appeals to the millions of women who are so excited to be pregnant and are searching for any possible clues about their future bundle of joy. Rather than having to wait until 20 weeks to find out with an ultrasound, moms-to-be can take the test as early as 10 weeks into their pregnancy.”
IntelliGender uses first morning urine and a proprietary mix of chemicals that react with a combination of hormones to indicate the gender.
“We feel that TransMedia Group is the perfect PR firm to represent our innovative product based on their success in helping to make brands such as Celsius and Rexall Sundown household names,” noted Teresa Garland, co-founder of IntelliGender.